Dr. Sanjeev Bhojraj

Sanjeev is a co-founder of Kailash Capital Research, LLCResearch, LLC . He is also a portfolio manager and co-founder of L2 Asset Management. Dr. Bhojraj is widely published in the top journals in finance and accounting and specializes in behavioral finance. With 19 Years of total experience, Dr. Bhojraj is also a Chaired Professor in Asset Management and the co-Director of the Parker Center for Investment Research at Cornell University’s Business School. Dr. Bhojraj has a Ph.D, ACA, ACMA and B.Com.

April 25, 2024

Undervalued Energy Stocks: The Case for Adding Exposure

March 10, 2022|

Starting in May of 2020, KCR’s research team wrote nearly a dozen pieces making the case for oil. On September 8th, we published Oil Company Stocks to Buy, which summarized our work up to that point and pounded the table for investing in oil stocks. With oil trading below $70, we led out by explaining that oil and natural gas commodity prices did not need to rise to turn oil and gas stocks into powerhouses for investors.

Survivorship Bias Free Stock Data is Critical to Investors

February 25, 2022|

Before we show you how quality and reasonable valuations are the breeding grounds of greatness, let’s talk about a common analytical error. When analyzing stocks and investment strategies, using bias-free data is a basic and critical first step. For a beautiful explanation, we guide you to Teddy Koker, a researcher at MIT’s Lincoln Labs, elegant walk-through, complete with programming instructions. For those interested in a less complex example, this post is for you.

Hillenbrand Investor Relations has an Incredible Story…

February 18, 2022|

(And nobody is listening, hence the opportunity). Hillenbrand 60 Second Summary: • $3.5bn market cap • Double digit earnings growth • 2% dividend yield • Authorization to buy-back 10% of shares outstanding. • 11% FCF Yield so could buy that stock back from ongoing FCF • Founded in 1906 – longevity • If management just avoids making an expensive acquisition...

Hillenbrand Stock Price = Capital Discipline for Cheap

February 18, 2022|

• We have been proponents of investing in companies that make what you need, not what you want. • Behavioral errors often give investors the feeling that they “missed” a stock after it has risen • KCR believes that Hillenbrand lies at the intersection of two powerful themes we have highlighted: the opportunity in small-cap value stocks and finding growth at a reasonable price

Democratizing Finance: Agency Problems and Investment

February 16, 2022|

This work was inspired by UCLA Professor Michael Brennan’s efficient autopsy of the dot.com bubble. Published in 2004, the piece broke down the mania that led to the historic bubble in 2000. A misplaced belief in Efficient Markets, agency problems on Wall Street, and weak accounting rules figured large in his work.

Market Cap vs. Revenue: The Implications of 20x P/S Ratios

February 4, 2022|

The Chart Below Shows: • the market cap of just software stocks valued at over 10x price to sales is over $6 trillion • that means that software stocks priced at preposterous levels are now worth ~30% of US GDP • KCR thanks Scott McNealy for making investment decisions on stocks valued like this simple

Russell 2500 Growth Index vs Russell 2500 Value Index

February 2, 2022|

Past Performance Does Not Guarantee Future Results…. Particularly the RECENT Past. This paper makes the following three points: 1) The mean reversion in the 2500 benchmarks will continue, with growth falling sharply relative to value, 2) The reason for this is painfully simple in our view and 3) Allocators should move from index funds to active managers in the R2500G sector

Go to Top